Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical …
HGH Thyregod, DA Steinbrüchel, N Ihlemann… - Journal of the American …, 2015 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement
TH Jørgensen, HGH Thyregod, N Ihlemann… - European heart …, 2021 - academic.oup.com
Aims The aims of the study were to compare clinical outcomes and valve durability after 8
years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical …
years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical …
Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk
L Søndergaard, N Ihlemann, D Capodanno… - Journal of the American …, 2019 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is an alternative to surgical
aortic valve replacement (SAVR) in patients with severe aortic stenosis and intermediate or …
aortic valve replacement (SAVR) in patients with severe aortic stenosis and intermediate or …
Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery
R Gill, M Herbertson, A Vuylsteke, PS Olsen… - Circulation, 2009 - Am Heart Assoc
Background—Blood loss is a common complication of cardiac surgery. Evidence suggests
that recombinant activated factor VII (rFVIIa) can decrease intractable bleeding in patients …
that recombinant activated factor VII (rFVIIa) can decrease intractable bleeding in patients …
Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding
C Mérie, L Køber, PS Olsen, C Andersson, G Gislason… - Jama, 2012 - jamanetwork.com
Context The need for anticoagulation after surgical aortic valve replacement (AVR) with
biological prostheses is not well examined. Objective To perform a nationwide study of the …
biological prostheses is not well examined. Objective To perform a nationwide study of the …
[PDF][PDF] Five-year clinical and echocardiographic outcomes from the Nordic Aortic Valve Intervention (NOTION) randomized clinical trial in lower surgical risk patients
HGH Thyregod, N Ihlemann, TH Jørgensen… - …, 2019 - thevalveclub.com.br
Abstract Background: The Nordic Aortic Valve Intervention (NOTION) was designed to
compare transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement …
compare transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement …
Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic …
L Søndergaard, DA Steinbrüchel… - Circulation …, 2016 - Am Heart Assoc
Background—The Nordic Aortic Valve Intervention (NOTION) trial was the first to randomize
all-comers with severe native aortic valve stenosis to either transcatheter aortic valve …
all-comers with severe native aortic valve stenosis to either transcatheter aortic valve …
High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized …
AG Vedel, F Holmgaard, LS Rasmussen, A Langkilde… - Circulation, 2018 - Am Heart Assoc
Background: Cerebral injury is an important complication after cardiac surgery with the use
of cardiopulmonary bypass. The rate of overt stroke after cardiac surgery is 1% to 2 …
of cardiopulmonary bypass. The rate of overt stroke after cardiac surgery is 1% to 2 …
Unoperated aortic aneurysm: a survey of 170 patients
MJ Perko, M Nørgaard, TM Herzog, PS Olsen… - The Annals of thoracic …, 1995 - Elsevier
From 1984 to 1993, 1,053 patients were admitted with aortic aneurysm (AA) and 170 (15%)
were not operated on. The most frequent reason for nonoperative management was …
were not operated on. The most frequent reason for nonoperative management was …
[HTML][HTML] Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial
S Rafiq, DA Steinbrüchel, MJ Wanscher… - Journal of cardiothoracic …, 2014 - Springer
Background To evaluate if an opiate sparing multimodal regimen of dexamethasone,
gabapentin, ibuprofen and paracetamol had better analgesic effect, less side effects and …
gabapentin, ibuprofen and paracetamol had better analgesic effect, less side effects and …